First Look Analysts Research Calls for Thursday, December 22

Investing

Published: December 22, 2022 9:09 am

This report was sent to Briefing.com subscribers earlier today.

Upgrades:

> Helen of Troy (HELE) upgraded to Buy from Neutral at DA Davidson; tgt raised to $126

> Celularity (CELU) downgraded to Perform from Outperform at Oppenheimer

> Jefferies (JEF) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $37

> Nkarta (NKTX) downgraded to Perform from Outperform at Oppenheimer

> Alcon (ALC) initiated with a Buy at Mizuho; tgt $85

> Applied Digital Corporation (APLD) initiated with a Buy at H.C. Wainwright; tgt $4

> Boston Scientific (BSX) initiated with a Neutral at Mizuho; tgt $52

> Brookfield Asset Mgmt (BAM) initiated with an Outperform at RBC Capital Mkts; tgt $35

> ConnectOne Bancorp (CNOB) assumed with a Mkt Perform at Raymond James

> Cooper (COO) initiated with a Buy at Mizuho; tgt $375

> dLocal Limited (DLO) resumed with a Buy at BofA Securities; tgt $18

> Getty Images (GETY) initiated with an Outperform at Wedbush; tgt $6

> Glaukos (GKOS) initiated with a Neutral at Mizuho; tgt $48

> Global Business Travel Group (GBTG) initiated with an Outperform at Evercore ISI; tgt $8

> Ivanhoe Electric (IE) initiated with a Sector Perform at Scotiabank; tgt $14

> KLX Energy Services (KLXE) assumed with a Buy at EF Hutton; tgt $30

> Markel Corp (MKL) initiated with a Buy at Janney; tgt $1550

> Parsons (PSN) initiated with a Neutral at Robert W. Baird; tgt $50

> Procore Technologies (PCOR) initiated with a Buy at Loop Capital; tgt $70

> WesBanco Inc (WSBC) assumed with a Mkt Perform at Raymond James

> X4 Pharmaceuticals (XFOR) initiated with an Overweight at Cantor Fitzgerald; tgt $3